Clarifying the PSA grey zone: The management of patients with a borderline PSA
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clarifying the PSA grey zone: The management of patients with a borderline PSA
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
Volume 70, Issue 11, Pages 950-959
Publisher
Wiley
Online
2016-09-27
DOI
10.1111/ijcp.12883
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- European Randomised Study of Screening for Prostate Cancer (ERSPC) risk calculators significantly outperform the Prostate Cancer Prevention Trial (PCPT) 2.0 in the prediction of prostate cancer: a multi-institutional study
- (2016) Robert W. Foley et al. BJU INTERNATIONAL
- Prostate cancer risk prediction using the novel versions of the European Randomised Study for Screening of Prostate Cancer (ERSPC) and Prostate Cancer Prevention Trial (PCPT) risk calculators: independent validation and comparison in a contemporary Europe
- (2015) Cédric Poyet et al. BJU INTERNATIONAL
- The percentage of prostate-specific antigen (PSA) isoform [-2]proPSA and the Prostate Health Index improve the diagnostic accuracy for clinically relevant prostate cancer at initial and repeat biopsy compared with total PSA and percentage free PSA in men
- (2015) Martin Boegemann et al. BJU INTERNATIONAL
- Defining the learning curve for multiparametric magnetic resonance imaging (MRI) of the prostate using MRI-transrectal ultrasonography (TRUS) fusion-guided transperineal prostate biopsies as a validation tool
- (2015) Gabriele Gaziev et al. BJU INTERNATIONAL
- Multiparametric prostate magnetic resonance imaging in the evaluation of prostate cancer
- (2015) Baris Turkbey et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The clinical effectiveness and cost-effectiveness of the PROGENSA® prostate cancer antigen 3 assay and the Prostate Health Index in the diagnosis of prostate cancer: a systematic review and economic evaluation
- (2015) Amanda Nicholson et al. HEALTH TECHNOLOGY ASSESSMENT
- Prostate cancer and the PCP: the screening dilemma
- (2015) M. T. Rosenberg et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Comparison of MR/Ultrasound Fusion–Guided Biopsy With Ultrasound-Guided Biopsy for the Diagnosis of Prostate Cancer
- (2015) M. Minhaj Siddiqui et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Predicting High-Grade Cancer at Ten-Core Prostate Biopsy Using Four Kallikrein Markers Measured in Blood in the ProtecT Study
- (2015) Richard J. Bryant et al. JNCI-Journal of the National Cancer Institute
- The effect of bicycling on PSA levels: a systematic review and meta-analysis
- (2015) D Jiandani et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Multiparametric magnetic resonance imaging–targeted biopsy for the detection of prostate cancer in patients with prior negative biopsy results
- (2015) Hamidreza Abdi et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Magnetic resonance imaging–targeted vs. conventional transrectal ultrasound–guided prostate biopsy: Single-institution, matched cohort comparison
- (2015) Eric H. Kim et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Trans-rectal ultrasound visibility of prostate lesions identified by magnetic resonance imaging increases accuracy of image-fusion targeted biopsies
- (2015) Osamu Ukimura et al. WORLD JOURNAL OF UROLOGY
- Predicting High-Grade Cancer at Ten-Core Prostate Biopsy Using Four Kallikrein Markers Measured in Blood in the ProtecT Study
- (2015) Richard J. Bryant et al. JNCI-Journal of the National Cancer Institute
- Prostate cancer screening in Primary Health Care: the current state of affairs
- (2015) Weranja KB Ranasinghe et al. SpringerPlus
- Do prostate cancer risk models improve the predictive accuracy of PSA screening? A meta-analysis
- (2014) K. S. Louie et al. ANNALS OF ONCOLOGY
- First round of targeted biopsies using magnetic resonance imaging/ultrasonography fusion compared with conventional transrectal ultrasonography-guided biopsies for the diagnosis of localised prostate cancer
- (2014) Pierre Mozer et al. BJU INTERNATIONAL
- Prospective Study of Diagnostic Accuracy Comparing Prostate Cancer Detection by Transrectal Ultrasound–Guided Biopsy Versus Magnetic Resonance (MR) Imaging with Subsequent MR-guided Biopsy in Men Without Previous Prostate Biopsies
- (2014) Morgan R. Pokorny et al. EUROPEAN UROLOGY
- Impact of obesity on the predictive accuracy of prostate-specific antigen density and prostate-specific antigen in native Korean men undergoing prostate biopsy
- (2014) Jae Heon Kim et al. INTERNATIONAL JOURNAL OF UROLOGY
- Prospective Evaluation of Magnetic Resonance Imaging Guided In-bore Prostate Biopsy versus Systematic Transrectal Ultrasound Guided Prostate Biopsy in Biopsy Naïve Men with Elevated Prostate Specific Antigen
- (2014) Michael Quentin et al. JOURNAL OF UROLOGY
- Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up
- (2014) Fritz H Schröder et al. LANCET
- The role of magnetic resonance imaging in the diagnosis and management of prostate cancer
- (2013) James Thompson et al. BJU INTERNATIONAL
- Indications, results and safety profile of transperineal sector biopsies (TPSB) of the prostate: a single centre experience of 634 cases
- (2013) Lona Vyas et al. BJU INTERNATIONAL
- The PICTURE study — Prostate Imaging (multi-parametric MRI and Prostate HistoScanning™) Compared to Transperineal Ultrasound guided biopsy for significant prostate cancer Risk Evaluation
- (2013) Lucy A.M. Simmons et al. Contemporary Clinical Trials
- Influence of imaging and histological factors on prostate cancer detection and localisation on multiparametric MRI: a prospective study
- (2013) Flavie Bratan et al. EUROPEAN RADIOLOGY
- Value of Targeted Prostate Biopsy Using Magnetic Resonance–Ultrasound Fusion in Men with Prior Negative Biopsy and Elevated Prostate-specific Antigen
- (2013) Geoffrey A. Sonn et al. EUROPEAN UROLOGY
- Magnetic resonance spectroscopy imaging-directed transrectal ultrasound biopsy increases prostate cancer detection in men with prostate-specific antigen between 4-10 ng/mL and normal digital rectal examination
- (2013) Tarun Dilip Javali et al. INTERNATIONAL JOURNAL OF UROLOGY
- Improving Detection of Clinically Significant Prostate Cancer: Magnetic Resonance Imaging/Transrectal Ultrasound Fusion Guided Prostate Biopsy
- (2013) Ardeshir R. Rastinehad et al. JOURNAL OF UROLOGY
- Prostate Cancer Diagnosis: Multiparametric MR-targeted Biopsy with Cognitive and Transrectal US–MR Fusion Guidance versus Systematic Biopsy—Prospective Multicenter Study
- (2013) Philippe Puech et al. RADIOLOGY
- From prostate-specific antigen (PSA) to precursor PSA (proPSA) isoforms: a review of the emerging role of proPSAs in the detection and management of early prostate cancer
- (2012) Satoshi Hori et al. BJU INTERNATIONAL
- A Calculator for Prostate Cancer Risk 4 Years After an Initially Negative Screen: Findings from ERSPC Rotterdam
- (2012) Monique J. Roobol et al. EUROPEAN UROLOGY
- Prostate Cancer Screening in the Randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: Mortality Results after 13 Years of Follow-up
- (2012) G. L. Andriole et al. JNCI-Journal of the National Cancer Institute
- Diagnostic significance of [−2]pro-PSA and prostate dimension-adjusted PSA-related indices in men with total PSA in the 2.0–10.0 ng/mL range
- (2012) Kazuto Ito et al. WORLD JOURNAL OF UROLOGY
- Prostate-specific antigen 1.5-4.0 ng/mL: a diagnostic challenge and danger zone
- (2011) E. David Crawford et al. BJU INTERNATIONAL
- Comparison of risk calculators from the Prostate Cancer Prevention Trial and the European Randomized Study of Screening for Prostate Cancer in a contemporary Canadian cohort
- (2011) Greg Trottier et al. BJU INTERNATIONAL
- Contemporary Role of Prostate Cancer Antigen 3 in the Management of Prostate Cancer
- (2011) Marco Auprich et al. EUROPEAN UROLOGY
- Risk-Based Prostate Cancer Screening
- (2011) Xiaoye Zhu et al. EUROPEAN UROLOGY
- An Empirical Evaluation of Guidelines on Prostate-specific Antigen Velocity in Prostate Cancer Detection
- (2011) Andrew J. Vickers et al. JNCI-Journal of the National Cancer Institute
- Head-to-head comparison of two online nomograms for prostate biopsy outcome prediction
- (2010) Mário Oliveira et al. BJU INTERNATIONAL
- Systematic Review of Pretreatment Prostate-Specific Antigen Velocity and Doubling Time As Predictors for Prostate Cancer
- (2008) Andrew J. Vickers et al. JOURNAL OF CLINICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now